Oumar Gaye, MD, MPH

Philadelphia Department of Public Health

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1263 - Dolutegravir/Rilpivirine Switch Study in Persons with HIV and Chronic Kidney Disease: 24-week Assessment of Viral Suppression, Adherence, Treatment Satisfaction and Quality of Life
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET